Shoham S, Batista C, Ben Amor Y, Ergonul O, Hassanain M, et al.
2023-05-01 • eClinicalMedicine
2023-05-01 • eClinicalMedicine
The COVID-19 pandemic has disproportionately impacted immunocompromised patients. This diverse group is at increased risk for impaired vaccine responses, progression to severe disease, p...
Siender M, Bibangambah P, Kim JH, Lankowski A, Chang JL, et al.
2021-06-15 • Journal of the American Heart Association
2021-06-15 • Journal of the American Heart Association
BACKGROUND Although ≈70% of the world's population of people living with HIV resides in sub-Saharan Africa, there are minimal prospective data on the contributions of HIV infection t...
BACKGROUND Non-communicable diseases (NCDs) account for the majority of adult deaths worldwide, and 80% of these deaths occur in low and middle-income countries (LMICs). The burd...
Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JH, et al.
2007-04-01 • Journal of Infectious Diseases
2007-04-01 • Journal of Infectious Diseases
BACKGROUND: Relapses originating from hypnozoites are characteristic of Plasmodium vivax infections. Thus, reappearance of parasitemia after treatment can result from relapse, recrudesce...
Muiru AN, Bibangambah P, Hemphill LC, Sentongo R, Kim JH, et al.
2018-04-11 • Journal of Acquired Immune Deficiency Syndromes (1999)
2018-04-11 • Journal of Acquired Immune Deficiency Syndromes (1999)
BACKGROUND The utility and validity of cardiovascular diseases (CVD) risk scores are not well studied in sub-Saharan Africa. We compared and correlated CVD risk scores with carotid i...
Hotez PJ, Batista C, Amor YB, Ergonul O, Figueroa J, et al.
2021-08-03 • eClinicalMedicine
2021-08-03 • eClinicalMedicine
A Lancet Commission for COVID-19 task force is shaping recommendations to achieve vaccine and therapeutics access, justice, and equity. This includes ensuring safety and effectiveness ha...
